LDR (LDRH) Stock Price, News & Analysis

Company Overview

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company's primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company's VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company's Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company's traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

Key Stats

• Today's Range: $25.10 to $25.10
• 50-Day Range: N/A
• 52-Week Range: $16.33 to $47.12
• Volume: 123 shs
• Average Volume: 773,189 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 6.60%
• Price Target: N/A
• Consensus Rating: N/A

LDRH Stock Analysis - Frequently Asked Questions

How were LDR's earnings last quarter?

LDR Holding Co. (NASDAQ:LDRH) released its quarterly earnings results on Tuesday, May, 10th. The medical device company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. LDR's quarterly revenue was up 8.4% compared to the same quarter last year.

What other stocks do shareholders of LDR own?

Based on aggregate information from My MarketBeat watchlists, some other companies that LDR investors own include Ares Acquisition (AAC), Bristol-Myers Squibb (BMY), (KITE) (KITE), Ligand Pharmaceuticals (LGND), Neurocrine Biosciences (NBIX), Nektar Therapeutics (NKTR) and Pacira BioSciences (PCRX).

Company Calendar

• Last Earnings: 5/10/2016
• Ex-Dividend for 12/6 Dividend: 12/03/2024
• Dividend Payable: 12/06/2024
• Ex-Dividend for 12/26 Dividend: 12/20/2024
• Dividend Payable: 12/26/2024
• Today: 1/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LDRH
• CUSIP: N/A
• CIK: 1348324
• Web: www.ldr.com
• Phone: +1-512-3443333
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A